DM0000: The mark consists of the word "GENFIT" over the words "Towards Better Medicine" all appearing in white, with a partial white sphere containing a fanciful design appearing in white and blue, and all the elements centered within a blue rectangle.
GS0051: Pharmaceutical and veterinary preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; cultures of microorganism for medical, pharmaceutical or veterinary use; cells preparations for medical, pharmaceutical or veterinary use, in particular for gene therapy or cell therapy; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical or veterinary use; sanitary preparations for medical use; dietetic foodstuffs for medical use; food supplements
CC0000: The color(s) blue and white is/are claimed as a feature of the mark.
GS0441: Professional consultancy, not connected with the conduct of business, in the field of hepatology, gastroenterology, cholestatic, cardiovascular, metabolic, inflammation, autoimmune therapy
GS0421: Pharmaceutical research, namely, research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical and veterinary fields; basic and applied scientific research; technical research in the field of pharmaceutical studies; screening and selection of molecules for scientific research purposes; development and validation of biological tests, of cell tests and of genetic tests; Functional analysis of genomics to identify, characterize, validate or develop biologically active molecules; analysis of biological substances in biologic fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering surveying; analysis of technical projects; professional consultancy, not connected with the conduct of business, in the field of scientific research; research and development of new pharmaceutical products for third parties; scientific research in the field of pharmacy
Case File Event Statements
4/25/2017 - 8 years ago
4 - ASSIGNED TO EXAMINERType:DOCK
4/10/2017 - 8 years ago
1 - NEW APPLICATION ENTEREDType:NWAP
4/13/2017 - 8 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
4/14/2017 - 8 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILEDType:MDSC
4/25/2017 - 8 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
4/25/2017 - 8 years ago
6 - NON-FINAL ACTION E-MAILEDType:GNRT
4/25/2017 - 8 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
9/28/2017 - 7 years ago
8 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
10/11/2017 - 7 years ago
9 - ASSIGNED TO LIEType:ALIE
10/16/2017 - 7 years ago
10 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
10/16/2017 - 7 years ago
11 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
10/20/2017 - 7 years ago
12 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
10/26/2017 - 7 years ago
13 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
11/8/2017 - 7 years ago
14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILEDType:NONP
11/28/2017 - 7 years ago
15 - PUBLISHED FOR OPPOSITIONType:PUBO
11/28/2017 - 7 years ago
16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILEDType:NPUB
2/13/2018 - 7 years ago
17 - REGISTERED-PRINCIPAL REGISTERType:R.PR
2/13/2023 - 2 years ago
18 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILEDType:REM1
11/6/2023 - a year ago
19 - TEAS SECTION 8 & 15 RECEIVEDType:E815
5/4/2024 - 12 months ago
21 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.Type:C15A
5/5/2024 - 11 months ago
22 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILEDType:NA85
5/4/2024 - 12 months ago
20 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
Trademark
87401101
